{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:17Z","timestamp":1792799417177,"version":"4.5.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072585"],"award-info":[{"award-number":["82072585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8177249"],"award-info":[{"award-number":["8177249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Project of Anhui Educational Committee for Distinguished Scholars","award":["gxbjZD2020069"],"award-info":[{"award-number":["gxbjZD2020069"]}]},{"name":"512 Talent Cultivation Project of Bengbu Medical College","award":["by51201108"],"award-info":[{"award-number":["by51201108"]}],"id":[{"id":"https:\/\/ror.org\/01f8qvj05","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Anhui Provincial Major Science and Technology Project","award":["202003a07020024"],"award-info":[{"award-number":["202003a07020024"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>ARID1A is a key mammalian SWI\/SNF complex subunit that is mutated in 5% to 11% of lung cancers. Although recent studies have elucidated the mechanism underlying dysregulation of the switch\/sucrose non-fermentable (SWI\/SNF) complexes in cancers, the significance of ARID1A loss and its implications in lung cancers remain poorly defined. This study investigates how ARID1A loss affects initiation and progression of lung cancer. In genetically engineered mouse models bearing mutant Kras and a deficient Trp53 allele (KP), ARID1A loss (KPA) promoted lung tumorigenesis. Analysis of the transcriptome profiles of KP and KPA tumors suggested enhanced glycolysis following ARID1A loss, and expression of the glycolytic regulators Pgam1, pyruvate kinase M (Pkm), and Pgk1 was significantly increased in ARID1A-deficient lung tumors. Furthermore, ARID1A loss increased chromatin accessibility and enhanced hypoxia-inducible factor-1\u03b1 (HIF1\u03b1) binding to the promoter regions of Pgam1, Pkm, and Pgk1. Loss of ARID1A in lung adenocarcinoma also resulted in loss of histone deacetylase\u20091 (HDAC1) recruitment, increasing acetylation of histone-4 lysine at the promoters of Pgam1, Pkm, and Pgk1, and subsequently enhancing BRD4-driven transcription of these genes. Metabolic analyses confirmed that glycolysis is enhanced in ARID1A-deficient tumors, and genetic or pharmacologic inhibition of glycolysis inhibited lung tumorigenesis in KPA mice. Treatment with the small molecule bromodomain and extraterminal protein (BET) inhibitor JQ1 compromised both initiation and progression of ARID1A-deficient lung adenocarcinoma. ARID1A negatively correlated with glycolysis-related genes in human lung adenocarcinoma. Overall, ARID1A loss leads to metabolic reprogramming that supports tumorigenesis but also confers a therapeutic vulnerability that could be harnessed to improve the treatment of ARID1A-deficient lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study links ARID1A loss with enhanced glycolysis in lung cancer and demonstrates the preclinical efficacy of BET inhibitor therapy as a strategy to combat tumor growth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-21-0763","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T16:50:11Z","timestamp":1641401411000},"page":"791-804","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-5836","authenticated-orcid":false,"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."},{"name":"2Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[{"name":"3Department of Oncology, Xiangya Cancer Center Xiangya Hospital, Central South University, Changsha, China."},{"name":"4National Clinical Research Center for Geriatric Disorders and Key Laboratory of Molecular Radiation Oncology, Hunan Province, Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8358-3074","authenticated-orcid":false,"given":"Zhongmin","family":"Wang","sequence":"additional","affiliation":[{"name":"2Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."},{"name":"5Department of Radiology, Ruijin Hospital LuWan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1746-8454","authenticated-orcid":false,"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linling","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ke","sequence":"additional","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xu","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefang","family":"Zhang","sequence":"additional","affiliation":[{"name":"7State Key Laboratory of Neuroscience, Institute of Neuroscience, CAS Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Yuan","sequence":"additional","affiliation":[{"name":"7State Key Laboratory of Neuroscience, Institute of Neuroscience, CAS Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wei","sequence":"additional","affiliation":[{"name":"8Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qungang","family":"Shan","sequence":"additional","affiliation":[{"name":"2Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."},{"name":"5Department of Radiology, Ruijin Hospital LuWan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Chen","sequence":"additional","affiliation":[{"name":"2Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."},{"name":"5Department of Radiology, Ruijin Hospital LuWan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"2Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."},{"name":"5Department of Radiology, Ruijin Hospital LuWan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"3Department of Oncology, Xiangya Cancer Center Xiangya Hospital, Central South University, Changsha, China."},{"name":"4National Clinical Research Center for Geriatric Disorders and Key Laboratory of Molecular Radiation Oncology, Hunan Province, Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuliang","family":"Chen","sequence":"additional","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunquan","family":"Sun","sequence":"additional","affiliation":[{"name":"3Department of Oncology, Xiangya Cancer Center Xiangya Hospital, Central South University, Changsha, China."},{"name":"4National Clinical Research Center for Geriatric Disorders and Key Laboratory of Molecular Radiation Oncology, Hunan Province, Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Qiu","sequence":"additional","affiliation":[{"name":"7State Key Laboratory of Neuroscience, Institute of Neuroscience, CAS Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhen","family":"Deng","sequence":"additional","affiliation":[{"name":"3Department of Oncology, Xiangya Cancer Center Xiangya Hospital, Central South University, Changsha, China."},{"name":"4National Clinical Research Center for Geriatric Disorders and Key Laboratory of Molecular Radiation Oncology, Hunan Province, Xiangya Hospital, Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[{"name":"1Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical College, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"2025112417053425200_bib1","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2025112417053425200_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2025112417053425200_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/2159-8290.CD-16-1337","article-title":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","volume":"7","author":"Jordan","year":"2017","journal-title":"Cancer Discov"},{"key":"2025112417053425200_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer - biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025112417053425200_bib5","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41379-020-0592-2","article-title":"ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis","volume":"33","author":"Hung","year":"2020","journal-title":"Mod Pathol"},{"key":"2025112417053425200_bib6","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/j.jtho.2018.07.099","article-title":"ARID1A gene driver mutations in lung adenocarcinomas","volume":"13","author":"Karachaliou","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2025112417053425200_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"2025112417053425200_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-017-0411-5","article-title":"Clinical impact of extensive molecular profiling in advanced cancer patients","volume":"10","author":"Cousin","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2025112417053425200_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ng.3744","article-title":"ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice","volume":"49","author":"Mathur","year":"2017","journal-title":"Nat Genet"},{"key":"2025112417053425200_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2017.10.007","article-title":"Arid1a has context-dependent oncogenic and tumor suppressor functions in liver cancer","volume":"32","author":"Sun","year":"2017","journal-title":"Cancer Cell"},{"key":"2025112417053425200_bib11","doi-asserted-by":"crossref","first-page":"153156","DOI":"10.1016\/j.prp.2020.153156","article-title":"Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer","volume":"216","author":"Jang","year":"2020","journal-title":"Pathol Res Pract"},{"key":"2025112417053425200_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer","volume":"24","author":"Lissanu Deribe","year":"2018","journal-title":"Nat Med"},{"key":"2025112417053425200_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat Commun"},{"key":"2025112417053425200_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO.2017.75.3384","article-title":"Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing","volume":"36","author":"Rizvi","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025112417053425200_bib15","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"2025112417053425200_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"2025112417053425200_bib17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"2025112417053425200_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2025112417053425200_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41588-019-0569-6","article-title":"Genomic landscape of lung adenocarcinoma in East Asians","volume":"52","author":"Chen","year":"2020","journal-title":"Nat Genet"},{"key":"2025112417053425200_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/0008-5472.CAN-19-3922","article-title":"Loss of ARID1A promotes epithelial-mesenchymal transition and sensitizes pancreatic tumors to proteotoxic stress","volume":"81","author":"Tomihara","year":"2021","journal-title":"Cancer Res"},{"key":"2025112417053425200_bib21","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1038\/s41467-019-11403-6","article-title":"ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion","volume":"10","author":"Wilson","year":"2019","journal-title":"Nat Commun"},{"key":"2025112417053425200_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gutjnl-2017-315541","article-title":"ARID1A, a SWI\/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"key":"2025112417053425200_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"2025112417053425200_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2019.09.003","article-title":"Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8 T cells","volume":"51","author":"Ma","year":"2019","journal-title":"Immunity"},{"key":"2025112417053425200_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41588-019-0541-5","article-title":"ARID1A influences HDAC1\/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response","volume":"52","author":"Nagarajan","year":"2020","journal-title":"Nat Genet"},{"key":"2025112417053425200_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature13906","article-title":"Rapid modelling of cooperating genetic events in cancer through somatic genome editing","volume":"516","author":"S\u00e1nchez-Rivera","year":"2014","journal-title":"Nature"},{"key":"2025112417053425200_bib27","doi-asserted-by":"crossref","first-page":"e9856","DOI":"10.15252\/emmm.201809856","article-title":"Nf1 loss promotes -driven lung adenocarcinoma and results in Psat1-mediated glutamate dependence","volume":"11","author":"Wang","year":"2019","journal-title":"EMBO Mol Med"},{"key":"2025112417053425200_bib28","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1158\/0008-5472.CAN-05-0453","article-title":"2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro","volume":"65","author":"Zhu","year":"2005","journal-title":"Cancer Res"},{"key":"2025112417053425200_bib29","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41467-020-15819-3","article-title":"TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K\/AKT pathway and PPP metabolism","volume":"11","author":"Cheng","year":"2020","journal-title":"Nat Commun"},{"key":"2025112417053425200_bib30","doi-asserted-by":"crossref","first-page":"104511","DOI":"10.1016\/j.phrs.2019.104511","article-title":"Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy","volume":"150","author":"Abdel-Wahab","year":"2019","journal-title":"Pharmacol Res"},{"key":"2025112417053425200_bib31","doi-asserted-by":"crossref","first-page":"e0126459","DOI":"10.1371\/journal.pone.0126459","article-title":"Shikonin suppresses skin carcinogenesis via inhibiting cell proliferation","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"2025112417053425200_bib32","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1038\/s41388-018-0300-6","article-title":"ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors","volume":"37","author":"Berns","year":"2018","journal-title":"Oncogene"},{"key":"2025112417053425200_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13238-017-0442-2","article-title":"The SWI\/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"2025112417053425200_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2019.01.017","article-title":"Glutathione metabolism: an Achilles' heel of ARID1A-deficient tumors","volume":"35","author":"Gorrini","year":"2019","journal-title":"Cancer Cell"},{"key":"2025112417053425200_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2018.12.009","article-title":"Targeting the vulnerability of glutathione metabolism in ARID1A-deficient cancers","volume":"35","author":"Ogiwara","year":"2019","journal-title":"Cancer Cell"},{"key":"2025112417053425200_bib36","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1038\/s41467-020-16416-0","article-title":"Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming","volume":"11","author":"Suryo Rahmanto","year":"2020","journal-title":"Nat Commun"},{"key":"2025112417053425200_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2019.06.008","article-title":"A homeostatic Arid1a-dependent permissive chromatin state licenses hepatocyte responsiveness to liver-injury-associated YAP signaling","volume":"25","author":"Li","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2025112417053425200_bib38","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/gutjnl-2017-315490","article-title":"ARID1ASWI\/SNF component restrains pancreatic neoplasia formation","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"key":"2025112417053425200_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature11232","article-title":"The accessible chromatin landscape of the human genome","volume":"489","author":"Thurman","year":"2012","journal-title":"Nature"},{"key":"2025112417053425200_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41576-018-0089-8","article-title":"Chromatin accessibility and the regulatory epigenome","volume":"20","author":"Klemm","year":"2019","journal-title":"Nat Rev Genet"},{"key":"2025112417053425200_bib41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ccell.2020.03.004","article-title":"A deregulated HOX gene axis confers an epigenetic vulnerability in KRAS-mutant lung cancers","volume":"37","author":"Guerra","year":"2020","journal-title":"Cancer Cell"},{"key":"2025112417053425200_bib42","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/1078-0432.CCR-12-3904","article-title":"Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer","volume":"19","author":"Shimamura","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2025112417053425200_bib43","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"2025112417053425200_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"key":"2025112417053425200_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.aaz8455","article-title":"Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation","volume":"368","author":"Gilan","year":"2020","journal-title":"Science"},{"key":"2025112417053425200_bib46","doi-asserted-by":"crossref","first-page":"e2365","DOI":"10.1038\/cddis.2016.271","article-title":"Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents","volume":"7","author":"Klingbeil","year":"2016","journal-title":"Cell Death Dis"},{"key":"2025112417053425200_bib47","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.18632\/oncotarget.3551","article-title":"Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery","volume":"6","author":"Fu","year":"2015","journal-title":"Oncotarget"},{"key":"2025112417053425200_bib48","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1158\/1078-0432.CCR-15-1449","article-title":"Targeting MYCN-driven transcription By BET-bromodomain inhibition","volume":"22","author":"Henssen","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2025112417053425200_bib49","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1021\/acs.jmedchem.6b01761","article-title":"Drug discovery targeting bromodomain-containing protein 4","volume":"60","author":"Liu","year":"2017","journal-title":"J Med Chem"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/5\/791\/3051986\/791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/5\/791\/3051986\/791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:05:48Z","timestamp":1764021948000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/5\/791\/681781\/Chromatin-Remodeling-Induced-by-ARID1A-Loss-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3,3]]},"published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-21-0763","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22431045","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431063.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431054","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431063","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431051","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431060","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431057.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431054.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431048","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431057","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431051.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431060.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431045.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431048.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6513780","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6513780.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}